Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesley G Mitchell

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Acta Haematologica|March 22, 2006
The influence of age on in vitro plasmin generation in the presence of fibrin monomerNagina Parmar, Lesley G Mitchell, Leslie R Berry, et al.
Haematologica|May 10, 2007
Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically ill childrenStefan Kuhle, Pablo Eulmesekian, Brian Kavanagh, et al.
Blood|September 14, 2010
In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypesUlrike Nowak-Göttl, Kevin Dietrich, Daria Schaffranek, et al.
Thrombosis and Haemostasis|July 1, 2016
Safety, tolerability and clinical pharmacology of dabigatran etexilate in adolescents. An open-label phase IIa studyJacqueline M L Halton, Thorsten Lehr, Lisa Cronin, et al.
Thrombosis and Haemostasis|October 3, 2014
Increased requirement for central venous catheter replacement in paediatric oncology patients with deep venous thrombosis: a multicentre studyKetan Kulkarni, Jaqueline Halton, Maria Spavor, et al.
Thrombosis and Haemostasis|January 18, 2006
Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic eventsStefan Kuhle, Patti Massicotte, Maria Dinyari, et al.
Thrombosis and Haemostasis|August 17, 2018
Anticoagulant Effects of Dabigatran in Paediatric Patients Compared with Adults: Combined Data from Three Paediatric Clinical TrialsHugo Maas, Savion Gropper, Fenglei Huang, et al.
Pediatrics|February 25, 2009
Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trialNatalie Anton, Peter N Cox, M Patricia Massicotte, et al.
Thrombosis and Haemostasis|March 13, 2019
PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and DesignSarah H O'Brien, Danshi Li, Lesley G Mitchell, et al.
Blood Advances|June 12, 2025
Safety and Efficacy of Apixaban Thrombosis Prevention in the Obese Pediatric Patients with Acute Lymphoblastic LeukemiaVilmarie Rodriguez, Sarah H O'Brien, Etan Orgel, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Acta Haematologica|March 22, 2006
The influence of age on in vitro plasmin generation in the presence of fibrin monomerNagina Parmar, Lesley G Mitchell, Leslie R Berry, et al.
Haematologica|May 10, 2007
Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically ill childrenStefan Kuhle, Pablo Eulmesekian, Brian Kavanagh, et al.
Blood|September 14, 2010
In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypesUlrike Nowak-Göttl, Kevin Dietrich, Daria Schaffranek, et al.
Thrombosis and Haemostasis|July 1, 2016
Safety, tolerability and clinical pharmacology of dabigatran etexilate in adolescents. An open-label phase IIa studyJacqueline M L Halton, Thorsten Lehr, Lisa Cronin, et al.
Thrombosis and Haemostasis|October 3, 2014
Increased requirement for central venous catheter replacement in paediatric oncology patients with deep venous thrombosis: a multicentre studyKetan Kulkarni, Jaqueline Halton, Maria Spavor, et al.
Thrombosis and Haemostasis|January 18, 2006
Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic eventsStefan Kuhle, Patti Massicotte, Maria Dinyari, et al.
Thrombosis and Haemostasis|August 17, 2018
Anticoagulant Effects of Dabigatran in Paediatric Patients Compared with Adults: Combined Data from Three Paediatric Clinical TrialsHugo Maas, Savion Gropper, Fenglei Huang, et al.
Pediatrics|February 25, 2009
Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trialNatalie Anton, Peter N Cox, M Patricia Massicotte, et al.
Thrombosis and Haemostasis|March 13, 2019
PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and DesignSarah H O'Brien, Danshi Li, Lesley G Mitchell, et al.
Blood Advances|June 12, 2025
Safety and Efficacy of Apixaban Thrombosis Prevention in the Obese Pediatric Patients with Acute Lymphoblastic LeukemiaVilmarie Rodriguez, Sarah H O'Brien, Etan Orgel, et al.
Pageof 4